Suppressive DNA vaccination in myelin oligodendrocyte glycoprotein peptide-induced experimental autoimmune encephalomyelitis involves a T1-biased immune response

Journal of Immunology

Volumn 170, Issue 4, 2003, Pages 1806-1813

  Lobell, Anna ^a   Weissert, Robert ^b   Eltayeb, Sana ^a   De Graaf, Katrien L ^b   Wefer, Judit ^a   Storch, Maria K ^c   Lassmann, Hans ^c   Wigzell, Hans ^d   Olsson, Tomas ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY OF VIENNA   (Austria)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; DNA; DNA VACCINE; FAS LIGAND; GAMMA INTERFERON; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G2B; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; MYELIN BASIC PROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CPG ISLAND; FEMALE; IMMUNE RESPONSE; MAJOR HISTOCOMPATIBILITY COMPLEX; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TANDEM REPEAT; VACCINATION;

EID: 0037442140     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.4.1806     Document Type: Article

References (36)

1. + T cells against influenza virus induced by vaccination with nucleoprotein DNA. J. Virol. 72:5648.
2. Maecker, H. T., D. T. Umetsu, R. H. DeKruyff, and S. Levy. 1998. Cytotoxic T cell responses to DNA vaccination: dependence on antigen presentation via class II MHC. J. Immunol. 161:6532.
3. Waisman, A., P. J. Ruiz, D. L. Hirschberg, A. Gelman, J. R. Oksenberg, S. Brocke, F. Mor, I. R. Cohen, and L. Steinman. 1996. Suppressive vaccination with DNA encoding a variable region gene of the T-cell receptor prevents autoimmune encephalomyelitis and activates Th2 immunity. Nat. Med. 2:899.
4. Lobell, A., R. Weissert, M. K. Storch, C. Svanholm, K. L. de Graaf, H. Lassmann, R. Andersson, T. Olsson, and H. Wigzell. 1998. Vaccination with DNA encoding an immunodominant myelin basic protein peptide targeted to Fc of immunoglobulin G suppresses experimental autoimmune encephalomyelitis. J. Exp. Med. 187:1543.
5. Lobell, A., R. Weissert, S. Eltayeb, K. L. de Graaf, H. Lassmann, T. Olsson, and H. Wigzell. 1999. Presence of CpG DNA and the cytokine milieu determine the efficacy of suppressive DNA vaccination in experimental autoimmune encephalomyelitis. J. Immunol. 163:4754.
6. Ruiz, P. J., H. Garren, I. U. Ruiz, D. L. Hirschberg, L. V. Nguyen, M. V. Karpuj, M. T. Cooper, D. J. Mitchell, C. G. Fathman, and L. Steinman. 1999. Suppressive immunization with DNA encoding a self-peptide prevents autoimmune disease: modulation of T cell costimulation. J. Immunol. 162:3336.
7. Coon, B., L. L. An, J. L. Whitton, and M. G. von Herrath. 1999. DNA immunization to prevent autoimmune diabetes. J. Clin. Invest. 104:189.
8. Garren, H., P. J. Ruiz, T. A. Watkins, P. Fontoura, L. T. Nguyen, E. R. Estline, D. L. Hirschberg, and L. Steinman. 2001. Combination of gene delivery and DNA vaccination to protect from and reverse Th1 autoimmune disease via deviation to the Th2 pathway. Immunity 15:15.
9. Tsunoda, I., L. Q. Kuang, N. D. Tolley, J. L. Whitton, and R. S. Fujinami. 1998. Enhancement of experimental allergic encephalomyelitis (EAE) by DNA immunization with myelin proteolipid protein (PLP) plasmid DNA. J. Neuropathol. Exp. Neurol. 57:758.
10. Tsunoda, I., N. D. Tolley, D. J. Theil, J. L. Whitton, H. Kobayashi, and R. S. Fujinami. 1999. Exacerbation of viral and autoimmune animal models for multiple sclerosis by bacterial DNA. Brain Pathol. 9:481.
11. Bourquin, C., A. Iglesias, T. Berger, H. Wekerle, and C. Linington. 2000. Myelin oligodendrocyte glycoprotein-DNA vaccination induces antibody-mediated autoaggression in experimental autoimmune encephalomyelitis. Eur. J. Immunol. 30:3663.
12. Selmaj, K., C. Kowal, A. Walczak, J. Nowicka, and C. S. Raine. 2000. Naked DNA vaccination differentially modulates autoimmune responses in experimental autoimmune encephalomyelitis. J. Neuroimmunol. 111:34.
13. Weissert, R., A. Lobell, K. L. de Graaf, S. Y. Eltayeb, R. Andersson, T. Olsson, and H. Wigzell. 2000. Protective DNA vaccination against organ-specific autoimmunity is highly specific and discriminates between single amino acid substitutions in the peptide autoantigen. Proc. Natl. Acad. Sci. USA 97:1689.
14. Noseworthy, J. H., C. Lucchinetti, M. Rodriguez, and B. G. Weinshenker. 2000. Multiple sclerosis. N. Engl. J. Med. 343:938.
15. Jansson, L., P. Diener, A. Engstrom, T. Olsson, and R. Holmdahl. 1995. Spreading of the immune response to different myelin basic protein peptides in chronic experimental autoimmune encephalomyelitis in B10.RIII mice. Eur. J. Immunol. 25:2195.
16. Tuohy, V. K., M. Yu, L. Yin, J. A. Kawczak, and P. R. Kinkel. 1999. Regression and spreading of self-recognition during the development of autoimmune demyelinating disease. J. Autoimmun. 13:11.
17. McRae, B. L., C. L. Vanderlugt, M. C. Dal Canto, and S. D. Miller. 1995. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J. Exp. Med. 182:75.
18. Olsson, T. 1995. Critical influences of the cytokine orchestration on the outcome of myelin antigen-specific T-cell autoimmunity in experimental autoimmune encephalomyelitis and multiple sclerosis. Immunol. Rev. 144:245.
19. Weissert, R., K. L. de Graaf, M. K. Storch, S. Barth, C. Linington, H. Lassmann, and T. Olsson. 2001. MHC class II-regulated central nervous system autoaggression and T cell responses in peripheral lymphoid tissues are dissociated in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis. J. Immunol. 166:7588.
20. Nilsson, B., T. Moks, B. Jansson, L. Abrahmsen, A. Elmblad, E. Holmgren, C. Henrichson, T. A. Jones, and M. Uhlen. 1987. A synthetic IgG-binding domain based on staphylococcal protein A. Protein Engin. 1:107.
21. Weissert, R., E. Wallstrom, M. K. Storch, A. Stefferl, J. Lorentzen, H. Lassmann, C. Linington, and T. Olsson. 1998. MHC haplotype-dependent regulation of MOG-induced EAE in rats. J. Clin. Invest. 102:1265.
22. Muhallab, S., C. Lundberg, A. W. Gielen, O. Lidman, A. Svenningsson, F. Piehl, and T. Olsson. 2002. Differential expression of neurotrophic factors and inflammatory cytokines by myelin basic protein-specific and other recruited T cells infiltrating the central nervous system during experimental autoimmune encephalomyelitis. Scand J. Immunol. 55:264.
23. Hammarberg, H., O. Lidmam, C. Lundberg, S. Y. Eltayeb, A. W. Gielen, S. Muhallab, A. Svenningsson, H. Linda, P. H. van Der Meide, S. Cullheim, et al. 2000. Neuroprotection by encephalomyelitis: rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells. J. Neurosci. 20:5283.
24. Storch, M. K., A. Stefferl, U. Brehm, R. Weissert, E. Wallstrom, M. Kerschensteiner, T. Olsson, C. Linington, and H. Lassmann. 1998. Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain Pathol. 8:681.
25. Karpus, W. J., K. J. Kennedy, S. L. Kunkel, and N. W. Lukacs. 1998. Monocyte chemotactic protein 1 regulates oral tolerance induction by inhibition of T helper cell 1-related cytokines. J. Exp. Med. 187:733.
26. Karpus, W. J., and K. J. Kennedy. 1997. MIP-1α and MCP-1 differentially regulate acute and relapsing autoimmune encephalomyelitis as well as Th1/Th2 lymphocyte differentiation. J. Leukocyte Biol. 62:681.
27. Suda, T., T. Okazaki, Y. Naito, T. Yokota, N. Arai, S. Ozaki, K. Nakao, and S. Nagata. 1995. Expression of the Fas ligand in cells of T cell lineage. J. Immunol. 154:3806.
28. Leadbetter, E. A., C. R. Bourque, B. Devaux, C. D. Olson, G. H. Sunshine, S. Hirani, B. P. Wallner, D. E. Smilek, and M. P. Happ. 1998. Experimental autoimmune encephalomyelitis induced with a combination of myelin basic protein and myelin oligodendrocyte glycoprotein is ameliorated by administration of a single myelin basic protein peptide. J. Immunol. 161:504.
29. Noseworthy, J. H. 1999. Progress in determining the causes and treatment of multiple sclerosis. Nature 399:A40.
30. + T cell clones in the rat. Cloning methodology and interferon-γ secretion. J. Immunol. Methods 121:185.
31. Stefferl, A., U. Brehm, M. Storch, D. Lambracht-Washington, C. Bourquin, K. Wonigeit, H. Lassmann, and C. Linington. 1999. Myelin oligodendrocyte glycoprotein induces experimental autoimmune encephalomyelitis in the "resistant" Brown Norway rat: disease susceptibility is determined by MHC and MHC-linked effects on the B cell response. J. Immunol. 163:40.
32. Sondermann, P., R. Huber, V. Oosthuizen, and U. Jacob. 2000. The 3.2-A crystal structure of the human IgG1 Fc fragment-FcγRIII complex. Nature 406:267.
33. Janeway, C., P. Travers, M. Walport, and J. Capra. 1999. Immunobiology: The Immune System in Health And Disease. Churchill Livingstone, New York.
34. Ravetch, J. V., and S. Bolland. 2001. IgG Fc receptors. Annu. Rev. Immunol. 19:275.
35. Abdul-Majid, K. B., A. Stefferl, C. Bourquin, H. Lassmann, C. Linington, T. Olsson, S. Kleinau, and R. A. Harris. 2002. Fc receptors are critical for autoimmune inflammatory damage to the central nervous system in experimental autoimmune encephalomyelitis. Scand J. Immunol. 55:70.
36. Akira, S., K. Takeda, and T. Kaisho. 2001. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2:675.